Sullivan Diane E.
SEC insider (Form 3/4/5 filer). CIK 0001968736. Director at LEXICON PHARMACEUTICALS, INC. (LXRX) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in THE WOODLANDS, TX.
Companies Sullivan Diane E. has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Director
- AMARIN CORP PLC\UK (AMRN): Director
Sullivan Diane E.
CIK: 0001968736
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 3, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect89.3K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
43.5K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
35.7K shares- - Apr 18, 2026AMRN
AMARIN CORP PLC\UK
ExerciseDirect838 shares- - Apr 18, 2026AMRN
AMARIN CORP PLC\UK
Tax PaymentDirect403 shares at avg. $14.98$6K - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
103.8K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
89.3K shares- - May 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect36.8K shares- - Apr 18, 2025AMRN
AMARIN CORP PLC\UK
ExerciseDirect838 shares- - Apr 18, 2025AMRN
AMARIN CORP PLC\UK
Tax PaymentDirect437 shares at avg. $9.11$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 89,312 | - | $0 | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 43,478 | - | - | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 35,714 | - | - | Direct |
| Apr 18, 2026 |  AMRN AMARIN CORP PLC\UK | Exercise | 838 | - | $0 | Direct |
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | Tax Payment | 403 | $14.98 | $6,037 | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 103,806 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 89,312 | - | - | Direct |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 36,810 | - | - | Direct |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | Exercise | 838 | - | - | Direct |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | Tax Payment | 437 | $9.11 | $3,981 | Direct |
1-10 of 10 transactions